Clinical and molecular characterization of hidradenitis suppurativa: a practical framework for novel therapeutic targets

被引:4
|
作者
Moltrasio, Chiara [1 ]
Tricarico, Paola Maura [2 ]
Moura, Ronald Rodrigues [2 ]
Brandao, Lucas [3 ]
Crovella, Sergio [4 ]
Marzano, Angelo Valerio [1 ,5 ,6 ,7 ]
机构
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy
[2] IRCCS Burlo Garofolo, Inst Maternal & Child Hlth, Trieste, Italy
[3] Univ Fed Pernambuco, Ctr Med Sci, Dept Pathol, BR-50670901 Recife, Brazil
[4] Qatar Univ, Lab Anim Res Ctr LARC, Doha, Qatar
[5] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Via Pace 9, I-20122 Milan, Italy
[7] Univ Milan, Dept Pathophysiol & Transplantat, Via Pace 9, I-20122 Milan, Italy
关键词
2D-3D cells and organoids models; Autoinflammatory skin diseases; Biomarkers discovery; Causative genetic variants and disrupted pathways; Genotype-phenotype correlation; Hidradenitis suppurativa; Syndromic forms; Tailored treatment;
D O I
10.1159/000531496
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
N/A
引用
收藏
页码:836 / 839
页数:4
相关论文
共 50 条
  • [31] Comparison of clinical and sonographic scores in hidradenitis suppurativa and proposal of a novel ultrasound scoring system
    Nazzaro, Gianluca
    Passoni, Emanuela
    Muratori, Simona
    Moltrasio, Chiara
    Guanziroli, Elena
    Barbareschi, Mauro
    Veraldi, Stefano
    Marzano, Angelo, V
    ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2021, 156 (02) : 235 - 239
  • [32] Review of therapeutic trends in clinical trials for hidradenitis suppurativa: the rise of biologics and demographic under-representation
    Coleman, Madeline S.
    Mulligan, Kathleen M.
    OConnell, Katie A.
    Ahmad, Areebah
    Kim, Lori
    da Silva, Alexandra
    Newton, Jazmin
    Dellavalle, Robert P.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2024, 49 (02) : 172 - 173
  • [33] Efficacy results using a novel hidradenitis suppurativa endpoint, HiSCR (hidradenitis suppurativa clinical response), from the placebo-controlled phase of a phase 2 adalimumab study
    Jemec, Gregor
    Sobell, Jeffrey
    Scheinfeld, Noah
    Sood, Sarika
    Gu, Yihua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB42 - AB42
  • [34] Comprehensive study of hidradenitis suppurativa in the perspective of pathogenesis and clinical and histological therapeutic efficacy of fractional microneedling radiofrequency
    Kim, Dong Hyo
    Yang, Ji Hoon
    Cho, Soo Ick
    Yoon, Ji Young
    Moon, Jungyoon
    Kim, Ji Won
    Choi, Sungjun
    Suh, Dae Hun
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 81 - 81
  • [35] Efficacy Results Using a Novel Hidradenitis Suppurativa Endpoint, Hiscr (Hidradenitis Suppurativa Clinical Response), From The Placebo-Controlled Phase of a Phase 2 Adalimumab Study
    Scheinfeld, N. S.
    Sobell, J. M.
    Gu, Y.
    Sood, S.
    ANNALS OF EMERGENCY MEDICINE, 2013, 62 (04) : S151 - S151
  • [36] Molecular Characterization and Elucidation of Pathways to Identify Novel Therapeutic Targets in Pulmonary Arterial Hypertension
    Yao, Xiaoting
    Jing, Tian
    Wang, Tianxing
    Gu, Chenxin
    Chen, Xi
    Chen, Fengqiang
    Feng, Hao
    Zhao, Huiying
    Chen, Dekun
    Ma, Wentao
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [37] Clinical characterization of paediatric-onset hidradenitis suppurativa: results from a multicentre European study
    Prignano, Francesca
    Di Cesare, Antonella
    Nikolakis, Georgios
    Kanni, Theodora
    Giamarellos-Bourboulis, Evangelos J.
    Matusiak, Lukasz
    Szepietowski, Jacek C.
    Zouboulis, Christos C.
    EXPERIMENTAL DERMATOLOGY, 2022, 31 : 40 - 40
  • [38] Erratum zu: Klinische, pathologische und molekulare Biomarker der Hidradenitis suppurativa/Acne inversaErratum to: Clinical, pathology-associated and molecular biomarkers of hidradenitis suppurativa/acne inversa
    M. von Laffert
    R. E. Hunger
    A. A. Navarini
    C. C. Zouboulis
    Der Hautarzt, 2021, 72 (9): : 842 - 842
  • [39] Hidradenitis suppurativa presents a methylome dysregulation capable to explain the pro-inflammatory microenvironment: Are these DNA methylations potential therapeutic targets?
    Radhakrishna, Uppala
    Ratnamala, Uppala
    Jhala, Devendrasinh D.
    Uppala, Lavanya V.
    Vedangi, Aaren
    Patel, Maulikkumar
    Vadsaria, Nikita
    Shah, Sushma
    Saiyed, Nazia
    Rawal, Rakesh M.
    Mercuri, Santo Raffaele
    Jemec, Gregor B. E.
    Damiani, Giovanni
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (10) : 2109 - 2123
  • [40] Multiple molecular pathways in melanomagenesis: characterization of therapeutic targets
    Palmieri, Giuseppe
    Ombra, MariaNeve
    Colombino, Maria
    Casula, Milena
    Sini, MariaCristina
    Manca, Antonella
    Paliogiannis, Panagiotis
    Ascierto, Paolo Antonio
    Cossu, Antonio
    FRONTIERS IN ONCOLOGY, 2015, 5